Post-Acute Sequelae of COVID-19 clinical trials
58 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional Capacity
- Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)
- Long-Covid-19 Alleviation Through Learning Mindfulness Study
- Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
- A Study to Examine Anktiva for the Treatment of COVID-19.
- Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation
- A Study to Assess Anktiva in Patients With Long Covid-19.
- Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation
- Sauna for Long Covid
- Osteopathic Manipulative Therapy Effects on Post-Acute Sequelae of COVID-19 (PASC) or Long COVID
- Long COVID Brain Fog: Cognitive Rehabilitation Trial
- Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study
- Heat thErapy And mobiLity in COVID-19 Survivors
- SARS-CoV-2 Specific Monoclonal Antibody for Post-COVID-19 Conditions (Long COVID)
- CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
- Mind Body Intervention for Long COVID-19
- Water-based Activity to Enhance Recovery in Long COVID-19
- LIFT: Life Improvement Trial
- Non-invasive Treatment for Long COVID (Post COVID-19 Condition) Brain Fog
- Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS
- Acupuncture and Chinese Herbal Medicine for Long COVID
- Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
- Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2
- Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19
- PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
- Immune-mediated Pathogenic Mechanisms of Neuro-PASC in Veterans
- Cognitive-Sensorimotor Function in Long-COVID
- Cross-Sectional Evaluation of Persistence of SARS-CoV-2 Remnants After Recovery From Acute Infection
- A Study of Post COVID-19 Mechanisms for Chronic Lung Sequelae
- Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infection
- Predictors of Post-COVID-19 Clinical and Cognitive Consequences
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
- Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease
- Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2
- Antiviral Clinical Trial for Long Covid-19
- Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.
- Care for Veterans Post-COVID-19
- Multiparametric [18F]F-AraG Imaging in Post-Acute Sequelae of COVID-19 (PASC)
- Dietary Intervention to Mitigate Post-Acute COVID-19 Syndrome
- The Long COVID-19 Wearable Device Study
- A Multi-Center, Individually-Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Superiority Trial to Evaluate the Efficacy of the Combination of Maraviroc and Atorvastatin for the Treatment of Subjects With Long COVID
- SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction
- Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
- Harnessing Optimism and Perseverance in the Face of Long COVID-Español
- Understanding the Long-term Impact of COVID-19 in Adults
- Fareon Open Label Device Clinical Trial
- DMSO Dual-Route Therapy for Refractory Tinnitus in Long-COVID and Post-COVID-19 Vaccine Injury
- Cognitive Rehabilitation Therapy for COVID-19
- Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2
- Evaluating the Response of the Immune System of People with Long COVID (post SARS-CoV-2)
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Post-Acute Sequelae of COVID-19” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.